Cost–effectiveness of bronchial thermoplasty in commercially-insured patients with poorly controlled, severe, persistent asthma

References

• Moorman JE, Akinbami LJ, Bailey CM, et al. National surveillance of asthma: united states, 2001–2010. National center for health statistics Vital Health Stat 2012;3(35):1-67
   Google Scholar
• Heaney LG, Horne R. Non-adherence in difficult asthma: time to take it seriously. Thorax 2012;67:268-70
   PubMed Web of Science ®Google Scholar
• Cochrane GM, Horne R, Chavez P. Compliance in asthma. Resp. Med 1999;93(11):763-9
   PubMed Web of Science ®Google Scholar
• Mitzner W. Airway Smooth Muscle: the Appendix of the Lung. Am J Respir Crit Care Med 2004;169:787-90
   PubMed Web of Science ®Google Scholar
• Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention: updated 2007. Bethesda, MD: National Institutes of Health; 2007
   Google Scholar
• Solway J, Irvin CG. Airway Smooth Muscle as a Target for Asthma Therapy. N Engl J Med 2007;356:1367-9
   PubMed Web of Science ®Google Scholar
• Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma: Full Report 2007. National Heart, Lung, and Blood Institute. 2007
   Google Scholar
• Danek C, Lombard C, Dungworth D, et al. Reduction in airway hyperresponsiveness to methacholine by the application of RF energy in dogs. J Appl Physiol 2004;97:1946-53
   PubMed Web of Science ®Google Scholar
• Castro M, Rubin AS, Laviolette M, et al. Effectiveness and safety of bronchial thermoplasty in the treatment of severe asthma: a multicenter, randomized, double-blind, sham-controlled clinical trial. Am J Respir Crit Care Med 2010;181(2):116-24
   PubMed Web of Science ®Google Scholar
• Pavord ID, Cox G, Thomson NC, et al. Safety and efficacy of bronchial thermoplasty in symptomatic, severe asthma. Am J Respir Crit Care Med 2007;176(12):1185-91
   PubMed Web of Science ®Google Scholar
• Wechsler ME, Laviolette M, Rubin AS, et al. Bronchial Thermoplasty: long-term safety and effectiveness in patients with severe persistent asthma. J Allergy Clin Immunol 2013;132(6):1295-302
   PubMed Web of Science ®Google Scholar
• Thomson NC, Rubin AS, Niven RM, et al. Long-term (5 year) safety of bronchial thermoplasty: Asthma Intervention Research (AIR) trial. BMC Pulmonary Med 2011;8
   PubMedGoogle Scholar
• Pavord ID, Thomson NC, Niven RM, et al. Safety of bronchial thermoplasty in patients with severe refractory asthma. Ann Allergy Asthma Immunol 2013;111(5):402-7
   PubMed Web of Science ®Google Scholar
• Cox G, Miller JD, McWilliams A, et al. Bronchial thermoplasty for asthma. Am J Respir Crit Care Med 2006;173(9):965-9
   PubMed Web of Science ®Google Scholar
• Miller MK, Lee JH, Blanc PD, et al. TENOR risk score predicts healthcare in adults with severe or difficult-to-treat asthma. Eur Respir J 2006;28(6):1145-55
   PubMedGoogle Scholar
• Dolan CM, Fraher KE, Bleecker ER, et al. Design and baseline characteristics of the epidemiology and natural history of asthma: outcomes and Treatment Regimens (TENOR) study: a large cohort of patients with severe or difficult-to-treat asthma. Ann Allergy Asthma Immunol 2004;1:32-9
   Google Scholar
• Chipps BE, Zeiger RS, Dorenbaum A, et al. Assessment of asthma control and asthma exacerbations in the epidemiology and natural history of asthma: outcomes and treatment regimens (TENOR) observational cohort. Curr Respir Care Rep 2012;1(4):259-69
   PubMedGoogle Scholar
• Bousquet J, Mantzouranis E, Cruz AA, et al. Uniform definition of asthma severity, control, and exacerbations: document presented for the World Health Organization Consultation on Severe Asthma. J Allergy Clin Immunol 2010;126(5):926-38
   PubMed Web of Science ®Google Scholar
• Campbell JD, Spackman DE, Sullivan SD. The costs and consequences of omalizumab in uncontrolled asthma from a USA payer perspective. Allergy 2010;65(9):1141-8
   PubMed Web of Science ®Google Scholar
• Sullivan SD, Eisner MD, Campbell JD, Omachi TA. Risk of mortality associated with asthma exacerbation. Am J Respir Crit Care Med 2009;179:A4770
   Google Scholar
• Centers for disease control and prevention, national center for health statistics. compressed mortality file 1999-2007. CDC WONDER On-line Database, compiled from Compressed Mortality File 1999-2007 Series 20 No. 2M, 2010. Available from: http://wonder.cdc.gov/cmf-icd10.html [Last accessed on 24 Mar 2011]
   Google Scholar
• Danielson E. Health research data for the real world: the MarketScan databases. research and pharmaceutical division, Thompson Medstat. Jan. 2014. Available from: http://truvenhealth.com/Portals/0/Users/031/31/31/PH_13434%200314_MarketScan_WP_web.pdf [Last accessed on 01 June 2014]
   Google Scholar
• Red Book 2009: Pharmacy’s fundamental reference (Red book drug topics). Montvale, NJ: Physician’s Desk Reference, Inc; 2009.US Bureau of Labor Statistics
   Google Scholar
• Chained consumer price index urban us medical care. 2014 Data File. Available from: http://data.bls.gov/cgi-bin/surveymost?su [Last accessed on 01 Jun 2014]
   Google Scholar
• Yang Y, Brazier JE, Tsuchiya A, Young TA. Estimating a preference-based index for a 5-dimensional health state classification for asthma derived from the asthma quality of life questionnaire. Med Decis Making 2011.31(2):281-91
   Google Scholar
• Tsuchiya A, Brazier J, McColl E, Parkin D. Deriving preference-based single indices from non-preference based condition-specific instruments: Converting AQLQ into EQ5D indices. 2002;No. 02/1. Located at: Sheffield Health Economics Group: Health Economics and Decision Science Discussion Paper Series, Sheffield
   Google Scholar
• Braithwaite RS, Meltzer DO, King JT, et al. What does the value of modern medicine say about the $50,000 per quality-adjusted life-year decision rule? Med Care 2008;46(4):349-56
   PubMed Web of Science ®Google Scholar
• Paltiel AD, Fuhlbrigge AL, Kitch BT, et al. Cost-effectiveness of inhaled corticosteroids in adults with mild-to-moderate asthma: results from the asthma policy model. J Allergy Clin Immunol 2001;108(1):39-46
   PubMed Web of Science ®Google Scholar
• Neumann PJ, Cohen JT, Weinstein MC. Updating cost-effectiveness — the curious resilience of the $50,000-per-QALY Threshold. N Engl J Med 2014;371:796-7
   PubMed Web of Science ®Google Scholar